on 06 Feb 2024
Last Applicant/ Owned by
Oxford Business Park South Oxford OX4 2GX
GB
Serial Number
79352298 filed on 24th May 2022
Registration Number
7296103 registered on 06th Feb 2024
Correspondent Address
Rebecca Liebowitz Venable LLP
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Scientific and technological services, namely, scientific research and design relating thereto in the field of analytical sciences, biophysics, chemistry, biochemistry, biotechnology, molecular sciences and mass spectrometry; laboratory research services in the field of analytical sciences, biophysics, chemistry, biochemistry, biotechnology, molecular sciences and mass spectrometry; medical and phRead More
Scientific and technological services, namely, scientific research and design relating thereto in the field of analytical sciences, biophysics, chemistry, biochemistry, biotechnology, molecular sciences and mass spectrometry; laboratory research services in the field of analytical sciences, biophysics, chemistry, biochemistry, biotechnology, molecular sciences and mass spectrometry; medical and pharmacological research services; scientific research, namely, scientific analysis and testing being measurement of substances in the field of analytical sciences, biophysics, chemistry, biochemistry, biotechnology, molecular sciences and mass spectrometry; scientific analysis and measurement of molecules and characteristics in the field of analytical sciences, biophysics, chemistry, biochemistry, biotechnology, molecular sciences and mass spectrometry; bioanalysis services; scientific imaging services; biochemical analysis; scientific research and development services; medical research and medical development services in the field of immunology, genetic conditions, oncology, immuno-oncology, ophthalmology, haematology, neurology, respiratory diseases, metabolic conditions, infectious diseases and cardiovascular diseases; pharmaceutical research and development services; biological research and analysis; biomedical research services; biotechnological research, namely, biotechnology scientific testing, in the biotechnical, biomedical and pharmaceutical fields; chemical research and analysis; research and development of new products for others in the biotechnical, biomedical and pharmaceutical fields; pharmaceutical research and development for the pharmaceutical industry; research and development of vaccines and medicines; scientific research and development services in the field of antibodies; scientific research and development services in the field of antibody technology; scientific research and development services in the field of immunology; medical laboratory services; research of pharmaceuticals; research relating to molecular sciences; research relating to pharmaceuticals; biopharmaceutical research, development and testing being product testing services; drug discovery services; product development, namely, drug development services; pharmaceutical drug development services; conducting early evaluations in the field of new pharmaceuticals; scientific research and development of molecules for therapeutic purposes; consultancy, advisory and information services in relation to all the aforesaid services
11th 000101
11th 000101
Pharmaceutical and veterinary preparations and substances for the treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; biopharmaceutical preparations and substances for treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; chemical, biochemical and biological preparations for medical and veterinary purposes for the treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; cells, cell lines, and cell cultures, all being cells for medical use, for use in the production of proteins for therapeutic use; reagents for medical use, namely, proteins being medical therapeutic reagents; therapeutic antibodies; vaccines
11th 000101
11th 000101
Reagents for use in medical research and scientific research being biological analysis; proteins for use in the manufacture of pharmaceuticals and reagents; proteins in raw material form for use in medical research; cells, cell lines, and cell cultures, all being cells for clinical laboratory use, for use in the production of proteins for therapeutic use
11th 000101
11th 000101
No 79352298
No Service Mark
No 60895-582269
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 10th May 2024 | FINAL DISPOSITION PROCESSED |
| 10th May 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| 06th May 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 06th Feb 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 06th Feb 2024 | REGISTERED-PRINCIPAL REGISTER |
| 21st Nov 2023 | NOTIFICATION PROCESSED BY IB |
| 21st Nov 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 21st Nov 2023 | PUBLISHED FOR OPPOSITION |
| 01st Nov 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 01st Nov 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
